| Financial Year |
March 31 2023 |
| Monetary Funds |
346,575,057.28 |
| Held-for-trading Financial Assets |
1,078,305,315.05 |
| Notes Receivable |
70,237,116.34 |
| Accounts Receivable |
856,279,560.25 |
| Advances to Suppliers |
2,617,887.60 |
| Other Receivables |
26,498,633.61 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
531,989,358.85 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
24,963,101.14 |
| Total Current Assets |
3,165,147,829.92 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
-- |
| Fixed Assetes |
1,462,429,893.28 |
| Under-construction Projects |
115,407,427.25 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
159,032,321.01 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
45,522,820.89 |
| Deferred Income Tax Assets |
495,061.13 |
| Other Non-Current Assets |
45,592,152.01 |
| Sub-Total of Non-Current Assets |
1,854,625,595.90 |
| Total Assets |
5,019,773,425.82 |
| Short-Term Loans |
2,001,986.11 |
| Trading Financial liabilities |
42,536.61 |
| Notes Payable |
168,478,139.59 |
| Accounts Payable |
504,373,741.06 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
71,427,841.29 |
| Taxes Payable |
15,508,963.31 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
62,155,263.50 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
325,526,547.69 |
| Other Current Liabilities |
1,583,700.86 |
| Sub-Total of Current Liabilities |
1,163,281,034.26 |
| Long-term Loans |
362,642,969.45 |
| Bonds Payable |
703,986,216.61 |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
48,129,513.66 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
1,243,812,321.65 |
| Total Liabilities |
2,407,093,355.91 |
| Paid-In Capital(Or Share Stock) |
437,167,299.00 |
| Capital Surplus |
914,848,734.78 |
| Surplus Reserve |
132,666,819.80 |
| LESS:Treasury Stock |
41,172,685.42 |
| Undistributed Profits |
913,152,666.28 |
| Minority Stockholder's Interest |
119,156,780.86 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
2,493,523,289.05 |
| Owner's Equity（Stockholder's Equity） |
2,612,680,069.91 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
5,019,773,425.82 |
